Intravenous fosfomycin: the underdog player in the treatment of carbapenem-resistant Acinetobacter baumannii infections.
Maurizio GuastalegnameEnrico Maria TrecarichiAlessandro RussoPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2023)